Cargando…
Expanding options of supportive care in IgA nephropathy
Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis worldwide, with a potentially serious prognosis. At present, management of IgAN is primarily based on therapeutic lifestyle changes, and excellent blood pressure control and maximized supportive treatment with the comb...
Autores principales: | Maixnerova, Dita, Hartinger, Jan, Tesar, Vladimir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695500/ http://dx.doi.org/10.1093/ckj/sfad201 |
Ejemplares similares
-
Emerging Modes of Treatment of IgA Nephropathy
por: Maixnerova, Dita, et al.
Publicado: (2020) -
Immune abnormalities in IgA nephropathy
por: Gentile, Micaela, et al.
Publicado: (2023) -
Targeting complement in IgA nephropathy
por: Caravaca-Fontán, Fernando, et al.
Publicado: (2023) -
Systemic and targeted steroids for the treatment of IgA nephropathy
por: Locatelli, Francesco, et al.
Publicado: (2023) -
New Treatment Strategies for IgA Nephropathy: Targeting Plasma Cells as the Main Source of Pathogenic Antibodies
por: Maixnerova, Dita, et al.
Publicado: (2022)